Clinical and Biochemical Characteristics of the Study population.

<p>Data are mean ± SD values.</p><p>Abbreviations: BMI, body mass index; HDL-C, high density lipoprotein cholesterol; HOMA-beta, homeostasis model assessment of beta cell function index; HOMA-IR, homeostasis model assessment of insulin resistance index; NGT, normal-glucose tolerant; OGTT, oral glucose tolerance test; T2DM, type 2 diabetes mellitus.</p>a<p>Calculated using fasting plasma glucose (mmol/L) and fasting plasma insulin (mU/L) levels.</p

Comparison of clinical characteristics between subjects with and without the Pro12Ala variant of PPARγ2.

<p>All data are means±SD.</p><p>The abbreviations used see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0071985#pone-0071985-t001" target="_blank">Table 1</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0071985#pone-0071985-t002" target="_blank">2</a>.</p>a<p>Calculated using fasting plasma glucose (mmol/L) and fasting plasma insulin (mU/L) levels.</p>b<p><i>P</i><0.05.</p

Association of the Pro12Ala polymorphism with type 2 diabetes mellitus.

<p>Adjusted for age, sex, BMI, hypertension, and family history of diabetes.</p><p>Abbreviations: CI, confidence interval; OR, odds ratio. The other abbreviations used see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0071985#pone-0071985-t001" target="_blank">Table 1</a>.</p

Distribution of allele and genotype frequencies of the Pro12Ala polymorphism in study subjects stratified by BMI.

<p>Adjusted for age, sex, BMI, hypertension, and family history of diabetes.</p><p>The abbreviations used see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0071985#pone-0071985-t001" target="_blank">Table 1</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0071985#pone-0071985-t002" target="_blank">2</a>.</p